Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Brian Goff$1.7B
Market Cap • 22/04/20242007
(há 17 anos)
2013
(11 years ago)
NASDAQ
Listagem
Cambridge
Sede • Massachusetts393
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
AGIOSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.